Royal Bank of Canada’s Cue Health Inc. Common Stock HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-76
Closed 7734
2024
Q1
$0 Sell
76
-22
-22% -$5 ﹤0.01% 7780
2023
Q4
$0 Buy
+98
New +$33 ﹤0.01% 7748
2023
Q3
Sell
-407
Closed 7779
2023
Q2
$0 Sell
407
-6,320
-94% -$5.39K ﹤0.01% 7798
2023
Q1
$12K Sell
6,727
-11,462
-63% -$24.9K ﹤0.01% 6246
2022
Q4
$38K Buy
18,189
+15,063
+482% +$47.6K ﹤0.01% 6048
2022
Q3
$9K Sell
3,126
-530
-14% -$1.88K ﹤0.01% 6493
2022
Q2
$12K Sell
3,656
-789
-18% -$4.27K ﹤0.01% 6327
2022
Q1
$29K Sell
4,445
-1,210
-21% -$10.9K ﹤0.01% 6410
2021
Q4
$76K Buy
+5,655
New +$62.2K ﹤0.01% 6127

Other funds holding HLTH

Royal Bank of Canada's HLTH Position: Q2 2024 in Review

Royal Bank of Canada sold out of Cue Health Inc. Common Stock (HLTH) in Q2 2024, closing a stake of 76 shares.

Royal Bank of Canada first reported a position in HLTH in Q4 2021 and held it in 9 quarters. The position peaked at $76K in Q4 2021. 9 funds tracked by Wall St. Rank hold HLTH as of Q2 2024.

  • Royal Bank of Canada reported no remaining Cue Health Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 76 Cue Health Inc. Common Stock shares in Q2 2024.
  • Royal Bank of Canada first reported a position in Cue Health Inc. Common Stock in Q4 2021 and held it in 9 quarters.
  • Royal Bank of Canada's Cue Health Inc. Common Stock position peaked at $76K in Q4 2021.
  • 9 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q2 2024.

Based on Royal Bank of Canada's 13F filing for Q2 2024, filed 14 Aug 2024.